The UK's FT-SE 100 index started 1995 at 3,066 and finished the year at 3,689.3, up 20.3%, more or less in line with the expectations of UK market observers, and considered to be a good performance. Interest rates came down quicker than some expected during the year and the bond markets were stronger than anticipated. In the USA, the Dow Jones Industrial was up 33.5% to 5,117.12 by year-end from 3,833 in January, and in Japan, the Nikkei stood at 19,723 at the start of the year, finishing at 19,868.15, a rise of just 0.7%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze